Cheng Cui
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 2%
- Long-Term Effects of COVID-19
Papers in
- Surgery 9
- Pancreatic function and diabetes 3
-
- Antibiotics Pharmacokinetics and Efficacy 6
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- Haiyan Li (19 shared papers)Dongyang Liu (22 shared papers)Xueting Yao (11 shared papers)Chunli Song (4 shared papers)Miao Zhang (2 shared papers)Baoying Huang (1 shared paper)Wenjie Tan (1 shared paper)Peihua Niu (1 shared paper)
- Journals
- Current Drug Metabolism (4 papers)Frontiers in Pharmacology (4 papers)Clinical Pharmacokinetics (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Acta Pharmaceutica Sinica B (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Cheng Cui
41 papers receiving 2.1k citations
Cheng Cui's Hit Papers
Peers
Comparison fields: 5 of 131
- Infectious Diseases 1.3k
- Neurology 428
- Ophthalmology 143
- Pharmacology 143
- Computational Theory and Mathematics 168
Countries citing papers authored by Cheng Cui
This map shows the geographic impact of Cheng Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Cui more than expected).
Fields of papers citing papers by Cheng Cui
This network shows the impact of papers produced by Cheng Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Cui. The network helps show where Cheng Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Cheng Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Hit paper breakdown → | 2020 | 1862 |
| 2 | 2020 | 44 | |
| 3 | 2013 | 35 | |
| 4 | 2020 | 30 | |
| 5 | 2020 | 28 | |
| 6 | 2023 | 28 | |
| 7 | 2020 | 16 | |
| 8 | 2022 | 16 | |
| 9 | 2021 | 10 | |
| 10 | 2020 | 9 | |
| 11 | 2017 | 9 | |
| 12 | 2021 | 9 | |
| 13 | 2019 | 8 | |
| 14 | 2023 | 8 | |
| 15 | 2021 | 6 | |
| 16 | 2022 | 6 | |
| 17 | 2018 | 6 | |
| 18 | 2023 | 6 | |
| 19 | 2023 | 6 | |
| 20 | 2020 | 5 |
About Cheng Cui
Cheng Cui is a scholar working on Surgery, Pharmacology, Infectious Diseases, Pharmacology and Oncology, having authored 44 papers that have together received 2.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (6 papers), COVID-19 Clinical Research Studies (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Pancreatic function and diabetes (3 papers), Diabetes Treatment and Management (3 papers), Infant Nutrition and Health (2 papers) and Drug-Induced Ocular Toxicity (2 papers). The work is most often cited by research in Infectious Diseases (1.3k citations), Neurology (428 citations), Ophthalmology (143 citations), Pharmacology (143 citations) and Computational Theory and Mathematics (168 citations). Cheng Cui has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Haiyan Li, Dongyang Liu, Xueting Yao, Chunli Song, Miao Zhang, Baoying Huang, Wenjie Tan, Peihua Niu, Siyan Zhan and Roujian Lu. Their work appears in journals such as Current Drug Metabolism, Frontiers in Pharmacology, Clinical Pharmacokinetics, Clinical Pharmacology & Therapeutics and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.